Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Commentary: The Prognostic Value of Oligo-Recurrence Following Esophagectomy for Esophageal Cancer

  • Shinji Mine (Department of Esophageal and Gastroenterological Surgery, Juntendo University Hospital)
  • Received : 2023.09.27
  • Accepted : 2023.09.27
  • Published : 2023.11.05
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Kroese TE, van Laarhoven HW, Schoppman SF, et al. Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: a Delphi consensus study in Europe. Eur J Cancer 2023;185:28-39. https://doi.org/10.1016/j.ejca.2023.02.015 
  2. Gomez DR, Tang C, Zhang J, et al. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 2019;37:1558-65. https://doi.org/10.1200/JCO.19.00201 
  3. Iyengar P, Wardak Z, Gerber DE, et al. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol 2018;4:e173501. https://doi.org/10.1001/jamaoncol.2017.3501 
  4. Kang M, Kim W, Kang CH, et al. The prognostic value of oligo-recurrence following esophagectomy for esophageal cancer. J Chest Surg 2023 Sep 12 [Epub]. https://doi.org/10.5090/jcs.23.050 
  5. van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg 2019;269:621-30. https://doi.org/10.1097/SLA.0000000000003031 
  6. Straatman J, van der Wielen N, Cuesta MA, et al. Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME Trial. Ann Surg 2017;266:232-6. https://doi.org/10.1097/SLA.0000000000002171